Need professional-grade analysis? Visit stockanalysis.com
$4.36M
5.61
N/A
N/A
Price Chart
Risk-Adjusted Performance
Enzon Pharmaceuticals Inc (ENZN) Price Performance
Enzon Pharmaceuticals Inc (ENZN) trades on United States in USD. The company is classified in the Healthcare sector under the Biological Products industry. The stock currently trades at $0.06, down 2.00% from the previous close.
Over the past year, ENZN has traded between a low of $0.04 and a high of $0.13. The stock has lost 51.0% over this period. It is currently 54.8% below its 52-week high.
Enzon Pharmaceuticals Inc has a market capitalization of $4.36M, with a price-to-earnings ratio of 5.61.
About Enzon Pharmaceuticals Inc
Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.
Company Info
- Sector
- Healthcare
- Industry
- Biological Products
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $26,000
- EBITDA
- N/A
- Profit Margin
- 2992.31%
- EPS (TTM)
- -0.07
- Book Value
- -0.03
Technical Indicators
- 52 Week High
- $0.13
- 52 Week Low
- $0.03
- 50 Day MA
- $0.06
- 200 Day MA
- $0.07
- Beta
- 0.08
Valuation
- Trailing P/E
- 5.61
- Forward P/E
- N/A
- Price/Sales
- 167.84
- Price/Book
- -1.73
- Enterprise Value
- $6.40M